Olo Inc. (OLO) Dividend History

Company News

• OLO SECURITIES NEWS: Did the Olo Inc. (NYSE:OLO) Board Breach its Duties to Shareholders? Contact BFA Law about the Thoma Bravo Merger

  Securities law firm investigating potential breaches of fiduciary duties by Olo's board and executives in connection with Thoma Bravo's $2 billion all-cash acquisition at $10.25 per share.

  GlobeNewswire Inc.
• Why Olo Stock Went Up Today

  Olo, a restaurant technology company, reported strong financial results for Q4 2024, with revenue up 25% year-over-year. However, the company's customer base declined compared to 2022, raising concerns about competitive risks despite its financial strength and reasonable valuation.

  The Motley Fool
• 3 Wallet-Friendly Stocks Under $10 With Significant Upside Potential

  The article highlights three undervalued stocks under $10 - AdaptHealth, ADT, and Olo - that have strong growth potential and attractive fundamentals.

  Investing.com

  Featured Companies: ADT AHCO
• SoundHound (SOUN) Aids Restaurant Portfolio With Acquisitions

  SoundHound (SOUN) acquires Allset to transform voice-enabled food ordering across cars, TVs and devices, advancing AI-driven dining experiences.

  Zacks Investment Research

  Featured Companies: NVDA ORCL SOUN
• Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

  Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry. Senti Biosciences, Inc. (NASDAQ: SNTI) gained 83% to $0.5298 after the company reported a new strategic collaboration with Celest Therapeutics for the clinical development of SENTI-301A in China. Senti is eligible to receive up to $156 million in milestones and royalties. Tharimmune, Inc. (NASDAQ: THAR) shares climbed 57.8% to $0.2488 as the company disclosed the execution of an exclusive worldwide licensing agreement with Avior Inc. d/b/a Avior Bio, LLC to develop, market and commercialize a clinical-stage asset, AV104. TransMedics Group, Inc. (NASDAQ: TMDX) shares gained 56.7% to $63.03 after the company reported better-than-expected third-quarter sales results and issued strong FY23 revenue guidance. Singular Genomics Systems, Inc. (NASDAQ: OMIC) rose 39.1% to $0.5350. Olaplex Holdings, Inc. (NASDAQ: OLPX) gained 39% to $1.92 following strong quarterly results. Datadog, Inc. (NASDAQ: DDOG) climbed 28.6% to $102.28 after the company reported better-than-expected third-quarter results and issued strong guidance. Augmedix, Inc. (NASDAQ: AUGX) shares rose 24% to $5.64 following strong third-quarter results. Rover Group, Inc. (NASDAQ: ROVR) gained 23.7% to $7.99 following upbeat results. The company’s board also approved extension of share repurchase program with additional $100 million. MacroGenics, Inc. (NASDAQ: MGNX) rose 20.6% to $6.57 after posting a profit for the third quarter. Jowell Global Ltd. (NASDAQ: JWEL) climbed 18% to $1.96. Triumph Group, Inc. (NYSE: TGI) rose 17.6% to $9.30 following strong quarterly results. Alteryx, Inc. (NYSE: AYX) shares jumped 17.3% to $35.74 after the company reported better-than-expected third-quarter financial results. Unisys Corporation (NYSE: UIS) shares jumped 16.7% to $3.3780 after the company posted upbeat third-quarter results and raised FY23 revenue growth forecast. Thoughtworks Holding, Inc. (NASDAQ: TWKS) rose ...

  Benzinga

  Featured Companies: ADTN ALTO AMRC AURA CHRS CLOV DCGO DDOG EVCM EVER FGEN HIMS ICUI JWEL MDB MGNX MYGN NINE OLPX OPRT OSCR PLNT PRAA RMCO SAGE SANM SGRY SNOW SNTI STRL TASK TCMD TDUP TGI THAR TMDX TRIP UIS VMEO VTYX WLDS